Company Pharma Development Srl with Fiscal Code 32376616
recorded a turnover of 2024 of
32.560,
with a net profit of
-6.080
and having an average number of employees of
1.
The company operates in the field of Intermedieri în comerţul cu produse diverse having the NACE code 4619.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Pharma Development Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
334.385
295.192
141.755
113.198
90.443
56.432
53.314
19.366
5.213
32.560
Total Income - EUR
352.132
338.514
147.461
114.184
93.262
56.971
54.061
19.652
5.351
32.670
Total Expenses - EUR
374.163
320.059
154.937
-42.218
51.905
33.023
39.340
37.528
39.552
36.761
Gross Profit/Loss - EUR
-22.031
18.455
-7.476
156.402
41.357
23.948
14.721
-17.876
-34.202
-4.091
Net Profit/Loss - EUR
-22.031
18.455
-8.815
154.291
40.441
23.415
14.197
-18.065
-34.253
-6.080
Employees
1
1
1
1
1
1
1
1
1
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 528.1%, from 5.213 euro in the year 2023, to 32.560 euro in 2024.
Check the financial reports for the company - Pharma Development Srl
Financial Rating - PHARMA DEVELOPMENT SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Pharma Development Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Pharma Development Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Pharma Development Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Pharma Development Srl - CUI 32376616
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
30.076
15.646
1.530
1.503
1.511
1.633
2.260
1.108
468
154
Current Assets
125.552
123.885
82.837
138.981
67.538
90.980
65.360
60.236
68.345
83.944
Inventories
0
0
0
0
0
1.675
1.674
1.643
1.638
1.628
Receivables
60.507
41.895
48.231
59.042
58.200
55.635
52.817
56.885
61.494
80.929
Cash
65.045
81.990
34.606
79.939
9.339
33.670
10.869
1.708
5.213
1.386
Shareholders Funds
-28.131
-9.389
-17.826
136.793
60.881
83.142
58.850
40.967
6.591
474
Social Capital
225
223
438
432
426
418
408
410
408
406
Debts
183.935
149.077
102.806
3.739
8.168
9.471
8.788
20.381
62.222
84.305
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4619 - 4619"
CAEN Financial Year
4619
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
83.944 euro in 2024 which includes Inventories of
1.628 euro, Receivables of
80.929 euro and cash availability of
1.386 euro.
The company's Equity was valued at
474 euro, while total Liabilities amounted to
84.305 euro.
Equity decreased by -6.080 euro, from 6.591 euro in 2023, to 474 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Pharma Development Srl